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ABSTRACT OF THESIS
APPETITE-REGULATING HORMONES
IN ENERGY COMPENSATION WITH EXERCISE
Background: The appetite-regulating hormones may influence compensatory increases
in energy intake with exercise, although this causal relationship has been difficult to
prove in a longitudinal trial.
Methods: 37 participants (29 female) aged 18 to 40 years performed aerobic exercise 6
days (6d), 2 days (2d), or 0 days per week for 12-weeks. Concentrations of ghrelin,
leptin, glucagon-like peptide 1 (GLP-1), and insulin were assessed before (fasting,
minute 0) and after a standardized meal at minute 15, 30, 45, 60, 90, 120, 150, and 180.
Linear mixed-effects models were used to model the relationships between time point
(12 weeks vs. baseline) and group over time (minutes 0 to 180) for each hormone. For
2d and 6d, the total area under the curve (AUC) for post-prandial hormone changes from
pre-intervention to post was calculated and used to predict % body fat lost and energy
compensation, defined as the difference between expected weight loss (based on
exercise energy expenditure, ExEE) and changes in bodily energy stores. Energy
compensation was expressed as % energy compensated (compensation index, CI).
Results: The 2d and 6d expended 1,490.7 ± 122.1 and 2,750.5 ± 145.1 kcal while
exercising 188.8 ± 4.12 and 320.5 ± 3.7 min/week respectively (means ± SE, P<0.01).
CI did not differ between 2d and 6d (P=0.81), averaging 52%. Only 6d lost significant
body fat (-7.29% ± 2.13 vs -1.86% ± 4.12, P=0.03). For the mixed-effects model, ghrelin
(P=0.03) and leptin (P<0.01) had significant group by time interactions, decreasing to a
greater extent in 6d than 2d or control. Changes in AUC for ghrelin (delta-AUC)
predicted the percentage of fat loss controlling for CI and ExEE while changes in AUC
for leptin predicted CI controlling for ExEE and fat loss.
Conclusion: The 12-week changes in ghrelin and leptin are influenced by exercise
frequency in overweight to obese adults. Greater decreases in ghrelin delta-AUC are an
independent predictor of body fat loss attenuation, while greater leptin delta-AUC
decreases are an independent predictor of CI. These findings represent a novel
predictor of energy compensation and body fat loss with exercise.
KEYWORDS: Aerobic exercise, Weight loss, Energy compensation, Hunger hormones
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CHAPTER 1. Introduction
1.1

Background
Overweight (Body Mass Index [BMI] 25.0-29.9) and obesity (BMI ≥ 30.0) is a

growing epidemic, with over 70% of the United States population classified as
overweight or obese [1-4]. Obesity is a well-known risk factor in developing severe
comorbidities such as heart disease, type 2 diabetes, fatty liver disease, and certain
types of cancers, leading to early mortality [1, 2, 5]. The underlying cause of obesity is
excessive weight gain through excessive energy intake and/or insufficient energy
expenditure [5-7]. Energy intake has been observed to be influenced by physiological,
genetic, environmental, and social factors. However, recent literature has demonstrated
that physiological factors have the most significant impact [8, 9].
A commonly used obesity treatment strategy is exercise, increasing energy
expenditure to favor a negative energy balance. However, exercise may also influence
certain physiological factors, such as hormonal mediators of hunger, causing increases
in energy intake; therefore, compensating for energy expended through exercise to
resist desired weight loss.
1.2

Problem Statement
Many long-term and acute studies have investigated how different types of

variables of an exercise program affect the concentrations of the appetite-regulating
hormones and energy intake; however, the amount of research investigating the longterm consequence of these hormonal alterations is little to none [10-17]. Therefore,
investigating the effect of exercise frequency on appetite-regulating hormones and
determining how these hormonal changes influence the compensatory response to
exercise is a crucial need for determining how exercise can be used most effectively to
promote weight control.
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1.3

Research Questions
1.

Does aerobic exercise frequency, after a 12-week intervention, influence

postprandial changes in plasma acylated ghrelin, leptin, GLP-1, and insulin
concentrations?
2.

Can identifying hormonal changes and their influence on compensatory

responses to exercise determine which variables predict sufficient weight loss?

1.4

Hypothesis
1.

Ghrelin concentrations will increase while leptin and GLP-1

concentrations will decrease in response to a meal to a greater extent when
engaging in 6 weekly aerobic exercise sessions compared to 2 sessions after 12
weeks.
2.

Changes in hunger hormones after 12 weeks of exercise will predict body

fat loss, with changes in Ghrelin being negatively associated with body fat loss
and Leptin, GLP-1, and insulin being positively associated with body fat loss.

2

CHAPTER 2. Literature Review
2.1

Introduction
America is among the countries with the most significant overweight and obesity

rates, with rates continually rising [2, 3]. 70.9% of men and 61.9% of women are deemed
overweight (Body Mass Index [BMI] 25.0-29.9 kg/m²) or obese (BMI ≥ 30.0 kg/m²),
compared to 38% of men and 36.9% of women in all other countries [2, 3]. BMI is highly
correlated with adiposity and the development of comorbidities such as cardiovascular
disease, type 2 diabetes, fatty liver disease, and certain cancers [1, 5, 6, 18].
Adiposity begins with the amount of energy intake being more than the amount
energy expended [5, 6]. Energy intake is complex and controlled by many different
physiological, behavioral, psychological, and environmental factors [5, 7]. These factors
contribute to the imbalance between energy intake and expenditure among overweight
and obese individuals [2, 8]. Specific physiological factors include alterations in appetiteregulating hormones, posited to influence energy intake significantly [8, 9].
It is well-known that a diet-induced energy deficit can result in a negative energy
balance and weight loss [1, 19]. Among overweight to obese individuals, diet-induced
energy deficits are difficult to maintain due to changes in concentrations of appetiteregulating hormones functioning to increase sensations of appetite cues [1, 6, 19]. This
makes it extremely difficult to maintain significant weight loss. Exercise training is
another means for weight loss many individuals use, increasing energy expenditure to
promote a negative energy balance (known as exercise training-induced energy deficit)
[9-11, 16, 19-24]. Many acute/short- and long-term studies have investigated how an
exercise training-induced energy deficit may influence these hormones, with many
offering conflicting results [10-17, 21, 25-28]. Specific characteristics and behaviors such
as sex, body adiposity, and diet may contribute to the varying effects exercise has on
fasting- and postprandial concentrations of appetite-regulating hormones [10, 29-32].
3

Furthermore, the effects of different modes and frequencies of exercise on appetiteregulating hormone concentrations are not thoroughly understood, making it difficult for
health care professionals to prescribe the most effective exercise training program for
overweight to obese men and women [10, 12, 13, 15, 25, 28, 33]. The purpose of this
review is to investigate factors that can influence fasting and postprandial concentrations
of the appetite-regulating hormones, including the attributes of an exercise program.
2.2

Physiology of Hunger and Satiety Inducing Hormones
Appetite regulation is primarily driven by peptide hormone control, operating at the

brain, gut, and peripheral regions [8, 9, 34, 35]. These appetite-regulating agents
administer different inputs and signals from these regions that interact with various brain
systems [8, 35]. This includes the brainstem that receives neuronal inputs from the
digestive tract and the hypothalamus, which receives hormonal and nutritional signals
from peripheral blood circulation [8, 9, 35]. These signals are received directly by
neurons on the arcuate nucleus (ARC), a particular segment of the hypothalamus,
through the blood-brain barrier [8, 9, 34, 35]. Together, these systems collect information
about the body’s nutrient status and respond accordingly by controlling sensations of
hunger and satiety, influencing energy intake, and often playing a role in body weight
regulation [8, 9, 34, 35].
2.2.1

Appetite-Regulating Neurons of The Hypothalamus
Within the ARC, there are two classes of neurons that run adjacent to one

another: 1) the appetite-inhibiting neurons expressing pro-opiomelanocortin (POMC) and
cocaine- and amphetamine-regulated transcript (CART), and 2) the appetite-stimulating
neurons expressing neuropeptide Y (NPY) and agouti-related peptide (AgRP) [18, 3537]. Stimulation of the POMC-CART neurons will deactivate the hypothalamic feeding
centers, decreasing appetite or feeding behavior [8, 36, 38]. Notably, POMC reduces
appetite by releasing the neurotransmitter alpha-melanocyte-stimulating hormone (a4

MSH) [8, 36, 38]. A-MSH binds to the melanocortin-4 receptor (MC4-R) on the
paraventricular nucleus (PVN) [8, 36, 38, 39]. In response, PVN projects the stimulus to
other sites through the brain coordinating energy homeostasis [8, 30, 35]. This makes
MC4-R the critical receptor for appetite control and energy homeostasis [8, 36, 38]. The
other appetite-inhibiting neuron, CART, has been associated with sensory processing,
with decreased expression observed in food deprivation [8, 36]. Activation of both POMC
and CART is through the renowned anorexigenic hormone, leptin [40, 41].
2.2.2

Leptin
Leptin is a cytokine synthesized and released from adipocytes in response to

changes in energy stores and systemic energy balance [8, 18, 40, 41]. The main action
of leptin is to stimulate satiety while simultaneously inhibiting appetite [8, 18]. Leptin
circulates partially bound to plasma proteins, with concentrations proportional to the
degree of adiposity, and enters the ARC by diffusion [8, 18, 40]. The receptor of leptin
associated with energy homeostasis, secretory organs’ regulation, and innate and
adaptive immunity is found in the hypothalamus and defined as Ob-Rb.[8, 18, 40-42]
This receptor is a type I cytokine receptor and is encoded by the LEPR gene in humans
[42]. Ob-Rb is present at multiple hypothalamus sites, such as the ARC and PVN [35,
40]. The expression of the Ob-Rb receptor is in many different forms [40]. These forms
include the long-form, which is necessary for the action of leptin on appetite, and the
short form, which plays a role in transporting leptin across the blood-brain barrier [40].
The Ob-Rb receptor plays a significant role in early obesity development when a lack of
the receptor is expressed [40]. Leptin stimulates satiety is through POMC-CART
activation upon binding to the leptin receptor located on the ARC [8, 40]. Leptin’s
additional role of attenuating appetite is through NPY and AgRP activation upon binding
to NPY-G-protein-coupled receptors and melanocortin receptors located on ARC [8, 40].
Other leptin effects include increased insulin sensitivity through decreasing intracellular
5

lipid levels in skeletal muscle, liver, and pancreatic beta cells [41]. Since leptin's level of
secretion depends on adiposity, individuals with obesity typically have greater leptin
concentrations than lean counterparts [40, 41]. However, leptin resistance is often
experienced in obesity, mediated by leptin signaling inhibition [40, 41]. Leptin resistance
facilitates the sensation of hunger and leads to increased energy intake among
individuals with obesity [8]. Normal regulation of leptin in neurons of the ARC not only
stimulates POMC-CART activation but inhibits the appetite-stimulating neurons, NPY,
and AgRP [8, 18, 40-42].
2.2.3

NPY and AgRP
Throughout the ARC to the PVN and other hypothalamic sites, NPY neurons' are

expressed [36, 37]. NPY is one of the most abundant neuropeptides and most potent
orexigenic factors [8]. These neurons are inhibited by leptin and insulin while stimulated
by glucocorticoids and ghrelin [8, 36, 37]. The main physiological action of NPY is
appetite stimulation through the NPY-G-protein-coupled receptors Y1 and Y5 (Y1R/Y5R)
[8, 30, 36, 37]. Additionally, NPY represses the satiety stimulation effect of a-MSH by
producing AgRP signaling proteins [36]. AgRP is a ligand of the melanocortin receptor
subtypes MC3-R and MC4-R [8, 18, 30]. When AgRP binds, it represses a-MSH
production by blocking its receptor MC1-R [8, 39]. Primarily, signal activation of both
NPY and AgRP is through the well-known appetite stimulant ghrelin [8, 37].
2.2.4

Ghrelin
Ghrelin, or growth hormone (GH)-releasing peptide, is the single peripheral

peptide known to increase appetite [8]. Ghrelin directly stimulates the expression of
neurons NPY and AgRP in the ARC, consequently stimulating food intake [43]. Ghrelin
also promotes food intake due to its antagonizing effect on leptin, as ghrelin and leptin
compete for neuron interaction stimulating or inhibiting NPY [8]. Ghrelin is mainly
produced in the stomach by the endocrine cells of the fundus' gastric mucosa [8, 9, 44].
6

Ghrelin is also an endogenous ligand for the growth hormone secretagogue-receptor
type 1a (GHS-R1a) [8, 9, 44]. Several central nervous system (CNS) areas involved in
energy intake regulation, such as the mesolimbic dopaminergic system, dorsal vagal
complex, and the hypothalamic nuclei express GHS-R1a [8, 9, 44]. Besides appetite
stimulation, ghrelin has multiple effects such as GH, acetylcholine (ACTH), cortisol,
aldosterone, catecholamine, and prolactin secretion [8, 9, 44]. High ghrelin levels are
typically observed in the fasted state, which falls following meals [45, 46]. Ghrelin levels
are inversely correlated with adiposity and are slower postprandial decline among
overweight or obese [8, 47, 48]. This slower postprandial drop in ghrelin impairs mealinduced satiety, predisposing individuals with greater adiposity to greater energy intake
and potentially weight gain [45, 47, 48]. In contrast, peripheral peptides that are
associated with satiety, in addition to leptin, include cholecystokinin (CCK), peptide YY
(PYY), glucagon-like peptide-1 (GLP-1), and insulin [8, 9, 18].
2.2.5

CCK
The satiety inducing peptide hormone CCK is found extensively in the brain and

GI tract and was one of the first peptides discovered inside the gut in 1943 [49]. CCK
plays numerous physiological and neurological roles such as mediating digestion in the
small intestine through inhibiting gastric emptying, stimulating digestive enzyme release
in the pancreas, and stimulating gall bladder contraction and sphincter of Oddi
relaxation, which increases production and delivery of bile [8, 9, 18, 50, 51]. CCK also
mediates satiety through acting on CCK receptors in the CNS [8, 51, 52]. CCK is
produced and released by enteroendocrine cells in the mucosal lining of the duodenum
and jejunum (I cell, IC), and neurons in the enteric nervous system (ENS) and brain [8,
9, 18, 50, 51]. The stimulation of CCK release is primarily by fatty acids (FA) or specific
amino acids (AA) present in the chyme [8, 9, 18, 50, 51]. Other modes of CCK activation
include monitor peptide, CCK-releasing protein, and acetylcholine [8, 9, 18, 50, 51].
7

Other means of CCK inhibition include somatostatin (growth hormone-inhibiting
hormone), pancreatic peptide (PP), and trypsin (a pancreatic enzyme) [8, 9, 18, 50, 51].
There are many different forms of CCK; however, all forms bind to two distinct receptors:
CCK-A and CCK-B [8, 9, 18, 50, 51]. CCK-A is primarily located on vagal afferent and
enteric neurons in the pancreas with smaller amounts in the CNS and is mainly
responsible for sensations of satiety and inhibiting food intake [51]. To activate CCK-A
receptors, they require binding of sulfated tyrosine moiety of CCK-8 and CCK-33; these
forms have a high affinity for the CCK-A receptor [50, 51]. CCK-B is primarily found in
the CNS and does not affect food intake [50, 51]. Activation of CCK-B requires gastrin,
de-sulfated CCK, and CCK-4 (a CCK fragment) binding to activate; these forms have a
high affinity for the CCK-B receptor but low affinity for the CCK-A receptor [50, 51].
Intraperitoneally (IP) administered CCK can inhibit food intake by reducing meal size and
duration [52]. However, since CCK’s half-life is short (1-2 minutes), IP injection is most
effective immediately before a meal [8, 52]. CCK concentrations gradually increase over
10-30 minutes after meal initiation due to specific nutrients in the gut, primarily fat and
protein, and remain elevated for up to 5 hours [8]. In bodyweight regulation, CCK plays
an important role and may act synergistically with leptin, whereas leptin potentiates the
magnitude of feeding suppression signals produced by CCK [9, 51]. CCK-A deficiency
can, therefore, increase the development of obesity due to decreasing the binding of
CCK, resulting in decreased food reduction signals, leading to increased food intake and
weight gain [8, 9, 49, 51].
2.2.6

PYY
PYY, a gut-derived hormone, is produced by the intestinal L cells of the ileum,

colon, and rectum and secreted postprandially [8, 9, 18]. Postprandial concentrations of
PYY are proportional to the meal macronutrient content, with higher levels observed
after a high-fat meal than a high carbohydrate and protein meal [8]. Peripheral circulation
8

of PYY exists in two forms: PYY1-36 and PYY3-36, with PYY3-36 as the peripherally active
anorectic signal [8, 9, 18]. PYY3-36 is formed by cleavage of the N-terminal Tyr-Pro
residues by dipeptidyl peptidase IV (DPP-IV) and binds to Y2 receptors (Y2R) to inhibit
NPY neurons and stimulate POMC neurons [8, 9, 18]. The Y2R is a putative inhibitory
pre-synaptic receptor and is part of the Y family of G-protein coupled receptors [8, 9, 18].
These receptors are highly expressed on the NPY neuron in the ARC but not on POMC
neurons [9]. Binding of the Y2R agonist, PYY3-36, to its receptors, Y2R, stimulates
appetite inhibition by decreasing food intake sustained for 24-hrs [53, 54]. IP and intraARC (I-ARC) injection of PYY3-36 in obese and normal-weight individuals expresses
these appetite inhibition effects [53, 55]. Administered PYY3-36 in the peritoneum and IARC can also reduce weight gain; however, PYY can also have appetite-stimulating
effects [8, 9, 18, 53]. For instance, administered PYY3-36 in the intracerebroventricular
vein (ICV) stimulates food intake by binding the Y1R and Y5R in the PVN [55]. Y1R and
Y5R are also targeted by the orexigenic ARC NPY neurons, which increase appetite [8,
9, 18]. This hormone plays a significant role in appetite and weight regulation by
reducing energy intake and body weight gain when injected through the IP and I-ARC;
therefore, it is an essential appetite-regulating hormone to observe among obese and
overweight individuals [56]. Obese individuals can develop PYY deficiency due to a
lower endogenous PYY response after each meal than normal-weight individuals [8, 56].
PYY deficiency can alter appetite and weight gain regulation, thus reinforcing obesity [8,
56].
2.2.7

GLP-1
Another appetite-regulating peptide hormone that is 30 or 31 amino acids long

and derived from posttranslational processing of proglucagon is known as GLP-1 [8, 9,
18, 30, 57-61]. Activation of the proglucagon's posttranslational process includes
expression of the proglucagon gene, and transcription and cleavage of proglucagon
9

must occur [57-61]. Several organs express this gene, such as the alpha-cells (a-cells)
of the pancreas, intestinal enteroendocrine L-cells of the gut (specialized cells of the GI
tract/pancreas with endocrine function), and the caudal brainstem and hypothalamus
within the brain [8, 9, 18, 30, 57-61]. Within the a-cells of the pancreas, proglucagon is
cleaved and transcribed by site-specific prohormone convertase 2 (PC2), which
generates the active glucagon, glicentin-related polypeptide (GRPP), intervening peptide
1 (IP1), and major proglucagon fragment (derived from GLP-1, IP2, and GLP-2; Figure
1) [57, 61]. Within the intestinal enteroendocrine L-cells of the intestine, primarily the
jejunum/duodenum, the caudal brainstem, and hypothalamus, proglucagon is catalyzed
by PC1/3 to form glicentin formed by GRPP, glucagon, and IP1 [57, 59, 61]. Additional
products of processing glicentin include GRPP, oxyntomodulin (derived from
glucagon/IP1), IP2, GLP-1, or GLP-2 [57, 59, 61]. Along with oxyntomodulin and other
peptide hormones, GLP-1 is an incretin [59]. Incretins can enhance glucose-stimulated
insulin secretion by decreasing blood glucose levels in a glucose-dependent manner
[59]. GLP-1 is converted into two circulating bioactive forms, GLP17-36 amide and GLP1737

[57, 61]. GLP17-36 accounts for about 20% of active GLP-1, whereas GLP17-37 is the

most abundant form and accounts for about >80% [57, 61]. GLP11-37 is first catalyzed by
endopeptidase to GLP17-37 [57, 61]. Next, GLP17-36 is amidated by the glycine terminal
AA, which serves as a substrate for C-terminal arginine, producing the active GLP17-36
[57, 61]. After the bioactive forms are released, they are rapidly degraded by dipeptidyl
peptidase (DPP)-4 to GLP19-36 or GLP19-37; thus, explaining why GLP-1 has a short
half-life (1-2 minutes) in blood circulation [8, 57, 61]. GLP-1 has various physiological
functions in the gut, brain, and pancreas [8, 9, 18]. GLP-1 in the gut inhibits gastric
emptying, acid secretion, and motility, which collectively result in decreased appetite [8,
9, 18]. In the brain, GLP-1 has correlated with neurotrophic (neurogenesis) and
neuroprotective (necrotic/apoptotic signaling and cell death reduction) effects [61].
10

Within regions of the brain such as the brainstem and hypothalamus, GLP-1 activates
certain neurons in the ARC and PVN, the solitary tract's nucleus, and area postrema that
lead to decreased appetite [61]. Looking at the pancreas, the most notable ability of
GLP-1 is promoting insulin secretion through a glucose-dependent manner, inhibiting
glucagon secretion, and replenishing beta-cell insulin stores during secretion [57, 61].
GLP-1 replenishes beta-cell insulin stores by promoting insulin gene transcription,
mRNA stability, and mRNA biosynthesis [57, 61]. The binding of GLP-1 initiates these
actions to its receptor, which is a G-protein coupled receptor [57, 61]. Many tissues such
as pancreatic islet cells, lung, heart, kidney, stomach, intestine, pituitary, skin, vagus
nerve, and certain CNS regions such as the brainstem and hypothalamus express the
GLP-1 receptor (GLP-1R) [8]. Effects of ICV and IP administration of GLP-1R agonists
(exenatide, lixisenatide, liraglutide) are consistently associated with decreased food
intake and weight loss, whereas effects of ICV and IP administration of GLP-1R
antagonists (NPY, exendin9-39) include increased food intake weight gain [57, 62].
Figure 1 below describes the physiological mechanisms of GLP-1 production.
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GRPP
Glicentin

Pro-glucagon

IP-2

Products:
GRPP
1 → 30

►

Glucagon
33 → 61

Oxyntomodulin

Brain &
Gut

►

IP−1
64 → 69

►

GLP−1
72 → 107/108

►

IP−2
111 → 123

GLP-1

GLP-2

Glucagon

MPGF

GRPP

IP-1

Pancreas

Figure 1. Products of pre-proglucagon cleavage Numbers (#→#) denote amino acid
residues at which cleave occurs. GRPP; Glicentin-related pancreatic polypeptide,
MPGF; Major pro-glucagon fragment.
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2.2.8

Insulin
Lastly, another critical hormonal regulator of appetite and the first peptide

hormone discovered is the anabolic hormone insulin [8, 9, 18, 30]. Insulin has various
metabolism and appetite regulation roles; weight control; insulin also has a lipo-static
role similar to leptin [8, 9]. Like leptin, circulating insulin levels are proportional to the
degree of adiposity [8, 9]. Insulin has a half-life of approximately 4-6 minutes, and levels
increase rapidly after meal consumption [57]. ICV administered insulin reduces food
intake and body weight due to insulin receptors being highly concentrated and widely
distributed in the brain [62]. These effects are initiated primarily by the ARC by inhibiting
the NPY/AgRP neurons [59, 61, 62]. In circulation, insulin is produced and released by
the endocrine pancreas' beta cells and degraded within one hour [59, 61, 62]. Blood
circulation release of insulin can be stimulated by metabolic signals and vagal nerve
stimulation and inhibited by specific metabolic signals, epinephrine, and somatostatin [9,
59, 61, 62]. The effects of insulin are activated from receptor binding, with the receptor
found in the cell membrane [8, 9, 18, 30]. When insulin binds to the receptor, it triggers
the B subunits' autophosphorylation, molecules inside the receptor, and subsequently,
the phosphorylation of the insulin receptor substrates (IRS), which are proteins found
inside the cell [8, 57, 59]. Expressed IRS in neurons with appetite-regulating and weight
control effects consist of only two: IRS-1 and IRS-2 [8, 57, 59]. Increased food intake,
adiposity, and plasma leptin levels have been demonstrated when neuron-specific
disruption of the insulin receptor gene occurs [41]. Specifically, removing IRS-2 causes
increased food intake and adiposity [41]. When describing the effects of insulin,
interpretation is analogous to leptin [8, 9, 18, 41]. Through the adipo-insular axis, insulin
can stimulate leptin synthesis and secretion from white adipose tissue [8, 9, 18, 41]. The
relationship between insulin and leptin is typical in hypothalamic targets and common
signal transduction pathways in the pancreas, muscles, and liver [8, 9, 18, 41].Table 1
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shown below describes the physiological characteristics of the appetite-regulating
hormones.
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Table 1. Overview of the physiological mechanisms in correspondence to the
appetite-regulating hormones.
Region

Hormone/
Peptide

Primary Production Site

Receptor(s)

Effect on
Appetite

Medial ARC and other
hypothalamic sites
Stomach (endocrine cells
of the gastric mucosa of
the fundus)

Y1, Y5

Increase

GHS-R1a

Increase

Other Action(s)

Hunger
Brain

NPY

Peripheral

Ghrelin

Antagonizing
POMC actions
Stimulates
expression of
NPY/AgRP,
release of GH and
other pituitary
hormones, gastric
motility,
pancreatic
polypeptide (PP)
release

Satiety
Brain

POMC/aMSH

ARC

MC3-R, MC4-R

Decrease

Stimulates basal
metabolic rate

Peripheral

CCK

I-cells of duodenum,
jejunum; widespread CNS
expression

CCK-A, CCK-B

Decrease

Peripheral

PYY

L-cells of distal small/larger
intestine; immunoreactivity
in hypothalamus, medulla

Y2

Decrease

Peripheral

GLP-1

L-cells of distal small/large
intestine; immunoreactivity
in hypothalamus,
dorsovagal complex,
pituitary

GLP-1 receptor

Decrease

Peripheral

Insulin

Insulin receptor

Decrease

Peripheral

Leptin

Beta cells of the endocrine
pancreas
Adipose tissue

Leptin receptor
(Ob-Rb)

Decrease

Stimulates
pancreatic
secretion, gall
bladder
contraction,
intestinal motility.
Inhibits gastric
motility
Inhibits
gallbladder
secretion, gut
motility,
pancreatic
secretion
Promotes
pancreatic B-cell
growth.
Inhibits glucagon
release, gastric
emptying, and
secretion
Various roles in
metabolism
Stimulates
POMC-CART,
increase insulin
sensitivity
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2.3
2.3.1

Appetite-Related Hormones in The Development of Obesity
Heterogeneity of Fasting and Postprandial Concentrations of Appetite-Regulating
Hormones
Many clinical trials investigate the effects exercise has on fasting and

postprandial concentrations of appetite-regulating hormones [10, 12, 13, 27]. However,
various findings are observed among these studies due to the heterogeneity in
methodologies and outcome measures [10, 12]. For example, different sex, body
adiposity, and diet are factors that can yield differentiating effects in appetite-regulating
hormone concentrations in response to exercise [12]. Thus, considering differences in
these variables is essential when concluding exercise for weight control interventions.
The findings of many exercise for weight control studies that do not monitor sex, body
adiposity, and diet differences are varied, limited, and call for further research to be
conducted [10, 12, 13, 21, 25, 27, 28]. Inversely, studies that do monitor sex, body
adiposity, and diet conclude equivocal findings of these characteristics and behaviors on
appetite-regulating hormone responses to acute (after a single exercise bout) or chronic
/ long-terms exercise interventions [12]. To further understand the influence sex has on
appetite responses to different types of exercise, recent studies that monitor these
characteristics and behaviors will be examined and discussed.
2.3.2

Sex
Taking sex differences into account during exercise for weight loss interventions

would minimize varied findings/results and improve understanding of the unknown
mechanisms that influence appetite with exercise. In the physiology of appetite and
energy intake, females and males have different activation and organization effects of
reproductive hormones (androgens & estrogens) [63]. The relatively permanent effects
of gonadal steroid hormones in early development or puberty are the organizational
effects [63]. Activation effects are relatively reversible effects at other life stages and
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require anatomic substrates in early development by sexually differentiated
organizational processes [63]. These reproductive hormones can influence many
mechanisms of appetite and energy intake [12, 63]. However, studies that analyze
exercise-induced changes in appetite-regulating hormones generally feature mostly
males participants [12]. Males in exercise and appetite research typically relate to
cyclical changes in reproductive hormones, whereas different phases of the menstrual
cycle in females influence the action of appetite-regulating hormones [64]. For example,
energy intake, plasma GLP-1, and insulin are suppressed during the follicular phase,
and total PYY concentrations are lower during the luteal phase of the menstrual cycle
[64, 65]. Research on exercise and appetite has recently focused on appetite changes
after exercise in females, suggesting that females compensate more for exerciseinduced energy deficits over more extended periods to preserve more body adiposity
than males [66].
Designated in Table 2, the purpose of this section is to discuss and consolidate
recent findings of the modulating effects of sex on concentrations of appetite-regulating
hormones with exercise-induced weight-loss interventions.
2.3.2.1 Acute Exercise
Comparisons of acute exercise-induced changes in appetite-regulating hormones
between females and males demonstrate that both sexes have similar changes in
appetite-stimulating responses [67-70]. It is essential to discuss that the female subjects
completed all trials in the follicular phase of the menstrual cycle within these studies,
which helped minimize the confounding effects on the measured appetite-regulating
hormones [67-70]. Effects of a single bout of vigorous-intensity exercise (70% VO2 peak)
on the appetite-stimulating hormone, acylated ghrelin, was suppressed in females and
males [67, 68, 71]. However, the effects of sex on the appetite-inhibiting hormones are
less conclusive [68-71]. For example, Panissa et al. reported no effect of exercise on
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PYY3-36, while Hagobian et al. indicated that PYY3-36 concentrations were increased after
exercise in only females [68, 71]. Hazell et al. also found elevations in total GLP-1
concentrations after moderate-intensity cycling (65% VO2 peak) and sprint interval
cycling in only females [69]. Hazell et al. also found that total GLP-1 concentrations
were elevated after moderate-intensity cycling (65% VO2 peak) and sprint interval
cycling in only females [69]. However, Shamlan et al. demonstrated that total GLP-1
concentrations were not affected by high-intensity intermittent or continuous low-intensity
cycling in females and males [70]. Due to the differentiating results in the literature, it is
difficult to conclude whether sex affects appetite-suppressing hormones in acute
exercise [67, 68, 70-72].
2.3.2.2 Chronic Exercise
Few studies have directly examined potential sex differences within the appetiteregulating hormones in response to chronic exercise [12]. Some report fasting leptin and
insulin concentrations are significantly reduced after a 12-week exercise intervention in
only females [73]. Similarly, after a four-day exercise intervention fasting leptin and
insulin concentrations are reduced [74]. In contrast, more significant reductions in insulin
and a greater elevation in acylated ghrelin were observed postprandially in overweight
and obese females than males, although findings reported no differences in fasting leptin
changes between females and males [74]. These studies' findings support the
suggestion that changes in the appetite-regulating hormones in response to exerciseinduced energy deficits are divergent in females compared to males [74]. However, due
to the insufficient amount of conducted research that observes how sex influences the
appetite-regulating hormones in response to chronic exercise, more exercise training
intervention studies need to be conducted before making a decisive conclusion [12].
Furthermore, most studies utilize aerobic exercise training interventions [12]. Thus, the
literature findings are restricted; therefore, conducting more research will investigate
18

potential sex differences in the appetite-regulating hormones with other exercise
modalities that may differ in duration and intensity.
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Table 2. Overview of articles that analyzed the modulating effects of sex on
concentrations of appetite-regulating hormones with exercise.
Source

Study Details

Type of
Exercise
(Mode/Intensity)

Study Population

Key Findings

Experiment 1:

Experiment 1:

90 minutes of
running (~70%
VO2 max)

Women, ~22.4
years, BMI ~22.0

Women exhibit
compensatory
appetite/gut
hormone/food intake
responses to acute
energy restriction but
no in response to
acute bout of exercise;
Men & women exhibit
similar acylated
ghrelin/PYY3−36
responses to exerciseinduced energy
deficits

Acute Exercise
Alajmi et
al. [67]

Panissa et
al. [71]

Hagobian
et al. [68]

Hazell et
al. [69]

Experiment 1: N = 12, three 9-hr
trials (control, exercise-induced
[Ex-Def], food restriction-induced
energy deficit [Food-Def]), identical
energy deficits imposed in Ex-Def
& Food-Def trials, compared
appetite/energy intake/acylated
ghrelin/PYY3−36 responses to an
equivalent energy deficit induced
by exercise or energy restriction
Experiment 2: N = 20, Two 7-hr
trials (Control & Exercise), 60
minutes of running performed at
beginning of exercise trial, directly
compared appetite/food
intake/circulating acylated ghrelin
responses to an exercise-induced
energy deficit in men vs. women
N = 20, compare the effects of
exercise intensity on appetite
control: relative energy
intake/hunger scores/appetiteregulating hormones, completed 6
session (2 screening/4
experimental) separated by at least
72-hr and a maximum of 1-wk for
men; Randomized crossover
design

N = 21, find whether acute exercise
suppresses relative energy intake
in both men/women exposed to
same relative exercise treatment,
Rested for 60 minutes or exercised
on a cycle ergometer (~70%
VO2 max) until 30% of total daily
energy expenditure was expended;
Counterbalanced/crossover design
N = 21, participated three sessions
in a randomized crossover design:
(1) MICT, 30-min cycling at 65%
VO2Peak; (2) SIT, 6 × 30 s "all-out"
sprints with 4-min recovery periods;
(3) control (CTRL; no exercise);
Determine whether
any sex difference in total PYY,
GLP-1 or perceived hunger exists
following MICT/SIT

Experiment 2:

60 minutes of
running (~70%
VO2 max)

Experiment 2:
Men (aged ~22.6
years) & women
(aged ~22.3
years), BMI ~22.423.1

High-intensity
intermittent allout exercise
(HIIE-A) for 60 x
8 seconds
interspersed by
12 seconds of
passive
recovery/Highintensity
intermittent
exercise (HIIE) at
100% of maximal
load attained in
incremental
test/Steady-state
exercise at 60%
of maximal load
(matched by work
done)/Control
session
Rested for 60
minutes or
exercised on a
cycle ergometer
(~70% VO2 max)

Men (n=11) &
women (n=9),
aged 27 ± 3 years,
physically active

None of exercise
protocols generated a
compensatory
increase in energy
intake in men/women;
Acylated
ghrelin/hunger
perception were more
suppressed and
cortisol/insulin were
more elevated in the
HIIE-A compared with
the control;
Regardless of sex,
Appetite hormones did
not have a major
impact on acute
energy intake

Men (n=11) &
women (n=10),
aged 21 ± 2 years,
BMI 26 ± 4 (men)/
24 ± 2 (women)

Regardless of sex
acute exercise to
suppress relative
energy intake is
effective

Moderateintensity
continuous
exercise
(MICT)/sprint
interval exercise
(SIT)

Men & women
(n=11), aged
28.6±5.9
(men)/30.5±7.9
(women) years,
BMI 23.7±2.2
(men)/23.5±2.8
(women)

Total PYY/GLP-1
respond differently to
exercise in
males/females over
90 minutes following
various exercise
intensities
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Table 2. (continued)
Source

Study Details

Type of Exercise
(Mode/Intensity)

Study Population

Key Findings

High-intensity
intermittent cycling
(HIIC)/low-intensity
continuous cycling
(LICC)

Men & women
(n=19), aged 18-35
years, BMI 23.6 ±
3.6, recruited from
the University of
Surrey and wider
community

High-intensity exercise,
if energy matched,
does not lead to
greater appetite or
energy intake, but may
exert additional
beneficial metabolic
effects that may be
more pronounced in
males

Women have higher
circulating leptin
concentrations despite
lower fat mass and
exercise training
appears to have a
greater effect on
systemic leptin levels in
females than in males
In women-exercise
altered energyregulating hormones in
a direction expected to
stimulate energy
intake, regardless of
energy status; In menthe response to
exercise was abolished
when energy balance
was maintained

Acute Exercise
Shamlan et
al. [70]

N = 40, undertook either highintensity intermittent cycling
(HIIC) consisting of 8 repeated
60-second bouts of cycling at
95% V̇O2 peak or low-intensity
continuous cycling (LICC),
equivalent to 50% V̇O2 peak,
matched for energy cost (∼950
kJ) followed by 90 minutes of
rest; Randomized crossover
design

Chronic Exercise
Hickey et
al. [73]

N = 18, determine the effect of
aerobic exercise training on
systemic leptin levels in
humans,
12-wk exercise training period;
Randomized crossover design

Aerobic exercise
training (4 day/wk., 3045 min/day)

Sedentary men &
women (n=9), age
48.8±1.8
(men)/45.6±1.7
years (women),
BMI 32.1±1.1
(men)/26.1±0.6
(women)

Hagobian
et al. [74]

N = 18, sedentary men and
women follow exercise training
programs with ad libitum
feeding, men lose body fat, but
women do not; Purpose of this
study was to evaluate whether
this observation could be
related to sex differences in the
way energy-regulating
hormones and appetite
perception respond to exercise;
Concentrations of hormones
related to the regulation of
energy intake/expenditure and
perception of hunger/satiety
were measured in three
conditions: 1) after a noexercise day with subjects in
energy balance, 2) after 4 days
of daily exercise with energy
added back to the baseline diet
to match the higher expenditure
and maintain energy balance
(BAL), and 3) after 4 days of
daily exercise without energy
added to the baseline diet, so
that subjects were in energy
deficit (DEF); Counterbalanced/cross-over study
design

Exercise bout was
conducted on a
treadmill (Life Fitness
9100, Schiller Park, IL)
at a moderate intensity
(50–65% of estimated
V̇O2 Peak) until 30% of
total daily energy
expenditure was
expended

Overweight/obese
sedentary men &
women (n=9), aged
26.8±11.8
(men)/23.3±8
(women), BMI
25.7±2.3
(men)/28.0±3.5
(women)
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2.3.3

Body Adiposity
Even with the continuous rise of obesity today, observations of significantly

varied whole-body adiposity are in individuals in westernized societies [75]. The wide
variability in whole-body adiposity levels is associated with numerous factors that
modulate energy intake/expenditure [12]. Current evidence suggests that body adiposity
can influence appetite-regulating hormone concentrations after exercise [26, 48, 76, 77].
Studies have indicated that fasting and post-prandial changes of certain appetiteregulating hormones such as PYY, GLP-1, and acylated ghrelin are lowered and
dampened as body fat increases [23, 78, 79]. Similarly, reports conclude that elevated
leptin and insulin concentrations among overweight and obese populations studies [78,
80]. However, continuous evaluation of leptin and insulin can result in these hormones'
resistance and ineffectiveness [12]. Many exercise-induced weight control interventions
that measure appetite-regulating hormone concentrations have been conducted at
varying BMI levels, thus increasing individual variability in the changes in these
hormonal concentrations [12]. Since BMI is unable to differentiate between fat mass
from fat-free mass and can lead to inaccurate descriptions of lean, overweight, or obese,
further studies should alleviate this discrepancy by defining body adiposity with specific
body fat percentages [12].
Identified in Table 3, the purpose of this section is to discuss and consolidate
recent findings of the modulating effects of body adiposity on concentrations of appetiteregulating hormones with exercise-induced weight-loss interventions.
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2.3.3.1 Acute Exercise
Studies have reported that among lean, overweight, and obese populations,
acylated ghrelin decreases and increases in PYY and GLP-1 during and after acute
aerobic exercise in both populations [13, 21, 81, 82]. For instance, Larsen and
colleagues found that after performing resistance exercise, total PYY and total GLP-1
did not change in overweight males (Average BMI: 29.9 kg/m²), with similar findings in
lean males (Average BMI: 23.7 kg/m²) [13, 21]. However, there are conflicting findings of
the appetite-regulating hormone responses after different exercise intensities among
lean, overweight, and obese subjects [12]. Two studies reported that neither moderatenor high-intensity cycling altered circulating PYY concentrations in overweight/obese
subjects, whereas a study conducted with lean subjects exhibited elevated PYY
concentrations at greater exercise intensities [15, 17, 83, 84]. On the other hand, Unick
et al. stated that overweight and obese females exhibited decreased GLP-1
concentrations 1-hr after a single bout of moderate-intensity walking [85]. Recently,
Holliday and Blannin demonstrated opposing results among overweight/obese subjects
in which GLP-1 was elevated 1-hr after low-volume sprint interval cycling [81].
These findings' variance could be due to the heterogeneity in methods and
outcome measurements among these studies. Others have mitigated this variability by
direct comparison of subjects with directly comparing the same protocol [26, 86, 87]. For
example, Ueda et al. observed that total PYY and GLP7-36 concentrations exhibited
similar elevations up to 1-hr after moderate-intensity exercise in both lean (BMI: 19.124.7 kg/m²) and overweight (BMI: 26.0-34.6 kg/m²) subjects [87]. Others have
demonstrated overweight/obese subjects (BMI: 25.3-35.4 kg/m²) exhibit more
outstanding total GLP-1 elevations after 60 minutes of moderate-intensity treadmill
exercise (59% VO2 peak), while the lean (BMI: 19.6-24.5 kg/m²) group exhibited more
significant elevations in exercise-induced total PYY concentration [26]. Regarding
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acylated ghrelin, reports concluded the opposite, such as no modifications of acylated
ghrelin concentrations in either overweight/obese or lean subjects after exercise were
found [26]. Although studies that involve exercise intensities larger than 60% VO2 Peak,
opposing results were found in which acylated ghrelin was suppressed [10, 11, 88, 89].
Even with inconsistent results among the given literature, the collective evidence
suggests that lean and overweight/obese individuals exhibit similar acute exerciseinduced changes in energy intake [12]. When conducting future studies, inclusions
should explain the inconsistencies in appetite-regulating hormones with varying body
adiposity levels regarding body adiposities that influence appetite-regulating hormones.
2.3.3.2 Chronic Exercise
Most recent exercise for weight control studies that analyze body adiposity’s
influence on appetite-regulating hormones are primarily conducted among
overweight/obese populations and conclude that exercise training increases fasting
hunger and postprandial satiety [15, 90]. Regarding the appetite-regulating hormones,
decreases in leptin concentrations and increases in GLP-1 concentrations have been
observed after four weeks of moderate-intensity cycling (55% VO2 Peak) in sedentary
overweight males (Average BMI: 25.6 kg/m²) [24]. Similarly, Pil-Byung et al. observed
decreases in leptin and total ghrelin concentrations after 8-weeks of combined
resistance/aerobic training in sedentary individuals (BMI: 25.5 kg/m²) [91]. Both studies
reported lower body weight and abdominal fat mass in response to exercise, which could
mediate post-training changes in the appetite-regulating hormones [24, 91]. These
findings suggest that individuals with more extensive pre-training adiposity exhibit more
significant changes in appetite-regulating hormones, which are proportional to reductions
in body fat post-intervention [24, 91]. A 12-week aerobic exercise intervention study
conducted by Gibbons and colleagues supports these findings [92]. After the exercise
intervention, in subjects who lost more weight, more massive elevated postprandial rises
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in GLP-1 and total PYY concentrations, with more massive suppression in acylated
ghrelin concentrations, were reported [15]. From a 12-weeks of high-intensity interval
training intervention, similar findings such as increases in fasting acylated ghrelin were
more significant in subjects that exhibited more extensive weight loss; however, this
relationship in PYY3-36, or GLP-1 concentrations were not found [15]. With decreased
bodyweight after aerobic exercise training, additional findings of acylated ghrelin, PYY336,

and GLP-1 reported no change in fasting or postprandial concentrations [16, 33, 93].

Decreases in body fat also do not correspond to changes in acylated ghrelin and PYY
concentrations after resistance exercise training in overweight and obese males [33].
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Table 3. Overview of articles that analyzed the modulating effects of body adiposity on
concentrations of appetite-regulating hormones with exercise.
Source

Study Details

Type of Exercise
(Mode/Intensity)

Study Population

Key Findings

AE/SE/CE each have own
distinct
effects on circulating
appetite-related
peptides/metabolites;
Despite differential
exercise-induced
hormone responses,
exercise mode appears to
have little effect on
perceived appetite
compared with a resting
control in this population
Differential response of
appetite-regulating
hormones to AER/RES
does not appear to
influence energy
intake in the post-exercise
meal

Acute Exercise
Larsen et al.
[13]

N = 12; Completed four
conditions in random
order; Perceived
appetite/appetite-related
peptides/metabolites
were assessed before/up
to 2-hr post-condition
(0P, 30P, 60P, 90P,
120P);
Randomized/counterbalanced study design

Completed four
conditions in a
random order: 1)
non-exercise control
(CON) (50 min
seated rest); 2) AE
(50 min cycling; 75%
VO2Peak); 3) SE (10
× 8 leg extensions;
75% 1RM); and 4)
CE (50% SE + 50%
AE)

Sedentary
overweight males
(n=12); aged 48 ± 5
years; BMI: 29.9 ±
1.9

BalagueraCortes et al.
[21]

N = 10; completed 3
trials in a counterbalanced design; study
investigated the effect of
an acute bout of
resistance exercise,
compared with aerobic
exercise, on subsequent
energy intake/appetiteregulating hormone
N =17; completed four
30-min experimental
conditions using a
randomized counterbalanced design;
examine the acute
effects of high-intensity
intermittent exercise
(HIIE) on energy intake,
perceptions of
appetite/appetite-related
hormones in sedentary,
overweight men

3 trials: (1)45 min of
resistance exercise
(RES; free and
machine weights),
(2) aerobic exercise
(AER; running), (3)
or a resting control
trial (CON)

Healthy active males
(n=10); aged 21.3 ±
1.4 years; BMI: 23.7
± 2.0

Four Conditions: (1)
CON: resting control,
(2) MC: continuous
moderate-intensity
exercise (60%
VO2Peak, (3) HI:
high-intensity
intermittent exercise
(alternating 60 s at
100% VO2Peak and
240 s at 50%
VO2Peak), (4) VHI:
very-high-intensity
intermittent exercise
(alternating 15 s at
170% VO2Peak and
60 s at 32% VO2
Peak)

Sedentary
overweight males
(n=17), aged 30 ± 8
years, BMI 27.7 ±
1.6,

Sim et al.
[84]
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High-intensity intermittent
exercise suppresses
subsequent ad-libitum
energy intake in overweight
inactive men

Table 3. (continued)
Source

Study Details

Type of Exercise
(Mode/Intensity)

Study Population

Key Findings

Four conditions: (1)
high-intensity
intermittent cycling
(HIIC), (2) moderateintensity continuous
cycling (MICC), (3)
short-duration HIIC
(S-HIIC), (4) and a
resting control
condition; Exercise
was performed 1-hr
after a standard
breakfast

Sedentary
overweight/obese
males & females
(n=7), aged 33.4 ±
10.0 years, BMI 32.3
± 2.7

In overweight/obese
individuals, isocaloric bouts
of moderate- or highintensity exercise lead to a
similar appetite response

60 minutes of 3
different exercise
trials: (1) control, (2)
steady-state
exercise (SSE), (3)
high-intensity
intermittent exercise
(HIIE)
Two trials: (1)
walking at a
moderate intensity
for approximately 40
minutes (2) or rested
for a similar duration

Healthy normal
weight males (n=12),
aged 22 ± 3 years,
BMI 23.7 ± 3.0

Acute bout of energymatched continuous
exercise/HIIE were equally
effective
at inducing an energy
deficit without stimulating
compensatory increases in
appetite
Hunger/energy intake were
unaltered by a bout of
walking suggesting that
overweight/obese
individuals do not acutely
compensate for the energy
cost of the exercise bout
through increased caloric
consumption

Exercise consisted
of 4 × 30 s “flat-out”
cycling on an
ergometer (adapted
Wingate test)

Active overweight
males & females
(n=4), aged 34 ± 12
years, BMI 27.7 ± 1.7

Acute Exercise
Martins et al.
[17]

Deighton et
al. [83]

Unick et al.
[85]

Holliday &
Blannin [81]

N = 12; assigned to the
control, MICC, HIIC, and
S-HIIC conditions, 1-wk
apart, in a counterbalanced order; aim of
the study was to
compare the effects of
acute isocaloric bouts
(250 kcal) of highintensity intermittent
cycling (HIIC)/moderateintensity continuous
cycling (MICC)/shortduration HIIC (S-HIIC)
(125 kcal)/a resting
control condition on the
appetite hormone
responses/subjective
feelings of
appetite/energy intake
(EI)/food reward in
overweight/obese
individuals
N = 12; completed three
8-hr trials (control),
steady-state exercise
(SSE), high-intensity
intermittent exercise
(HIIE)) separated by 1
week; Counter-balanced
Latin square design
N = 19; underwent two
experimental testing
sessions in a counterbalanced order: (1)
exercise and (2) rest;
study examined the
acute effect of a bout of
walking on hunger/
energy intake/appetiteregulating hormones
N = 8; completed resting
(REST)/exercise (EX)
trials in a counterbalanced order; Counterbalanced/crossover study
design
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Sedentary
overweight/obese
females (n=19), aged
18-45 years, BMI
25.0-39.9

Little as 4 × 30 s of “flatout” cycling was sufficient
to elicit a transient
suppression of appetite/an
enduring suppression of
plasma acylated ghrelin;
food intake 2-h postexercise was unaffected

Table 3. (continued)
Source

Study Details

Type of Exercise
(Mode/Intensity)

Study Population

Key Findings

Two trials: (1)
constant cycling
exercise at 50%
VO2Peak (2) or rest
for 60 min

Overweight/obese &
normal weight males
(n=7), middle-aged

Findings suggest that
short-term EB during a
single exercise session
might be regulated not by
increased amounts of these
gut hormones

Two trials: (1/2) 60
minutes treadmill
exercise (59%
VO2Peak) at 0-1-hr
and rested after

healthy lean (n=22,
11 females; aged
37.5 (15.2) years;
BMI 22.4 (1.5) and
overweight/obese
(n=25, 11 females;
45.0 (12.4) years,
BMI 29.2 (2.9)

Acute moderate-intensity
exercise transiently
suppressed
appetite/increased
PYY/GLP-1 in the hours
after exercise without
stimulating compensatory
changes in appetite in lean
or overweight/obese
individuals

4-week training at
55% of maximal
oxygen uptake
(VO2Peak) for each
condition

Healthy sedentary
males 33 ± 2 years;
BMI 25.6 ± 0.8

Hypoxic
training for 4 weeks
resulted in greater
improvement in glucose
tolerance without
loss of whole-body fat
mass, abdominal fat area
or IMCL; Hypoxic training
did not have synergistic
effect on the regulation of
appetite-related hormones

-

Healthy sedentary
males

Demonstrated the
beneficial effects of an
exercise program by
altering appetite-regulating
hormones, decreasing
inflammatory factors, and
improving lipid profiles and
body composition in
healthy young me

Acute Exercise
Ueda et al.
[87]

Douglas et
al. [26]

N = 14; examined
whether changes in gut
hormone levels due to a
single bout of aerobic
exercise differ between
obese young
males/normal controls;
attempted to determine
the involvement of
hormonal changes during
exercise in the regulation
of energy balance (EB);
Randomized crossover
design
N = 47; study compared
the acute effects of
moderate-intensity
exercise on
appetite/energy
intake/appetite-regulatory
hormones in lean and
overweight/obese
individuals; completed
two, 8-hr trials;
Randomized crossover
design

Chronic Exercise
Morishima et
al. [24]

Pil-Byung et
al. [91]

N = 22; conducted to
determine change in
regional fat accumulation
and appetite-related
hormonal response
following hypoxic
training; subjects
underwent hypoxic (n =
9, HYPO, FiO(2) = 15%)
or normoxic training (n =
11, NOR, FiO(2) =
20·9%) during a 4-week
period (3 days per week);
Randomized crossover
design
N =30; investigated the
effects of an exercise
program on appetiteregulating hormones,
inflammatory mediators,
lipid profiles, and body
composition; Randomly
assigned to two groups
(exercise group, EG,
N.=15 and control group,
CG, N.=15)
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Table 3. (continued)
Source

Study Details

Type of Exercise
(Mode/Intensity)

Study Population

Key Findings

16 completed 12
weeks of aerobic
exercise and 16 nonexercising control
subjects were
matched for age and
body mass index

Overweight/obese &
normal weight males
(n=16); age 18-55
years, BMI 27-34

No impact on postprandial
peptide release was found
after 12 weeks of aerobic
exercise; Responders to
exercise-induced weight
loss showed greater
suppression of acylated
ghrelin and greater release
of GLP-1 and total PYY at
baseline

three training
groups: (1) MICT (n
= 14), (2) HIIT (n =
16), (3) or shortduration HIIT (n =
16); three times per
week

Sedentary
overweight/obese
males & females
(n=30), age of 34.4 ±
8.8 years; BMI 33.3 ±
2

Study suggests that chronic
HIIT has no independent
effect on appetite or food
reward when compared
with an isocaloric program
of MICT in obese
individuals

AER and RES
completed 12 weeks
of training (3
sessions per week),
while CON continued
their sedentary
routine

Sedentary
overweight/obese
males; aged 49 ± 7
years; BMI 30.8 ± 4.2

Aerobic exercise training is
associated with an increase
in satiety, while an
equivalent period of
resistance training is not

Chronic Exercise
Gibbons et
al. [92]

Martins et al.
[17]

Guelfi et al.
[33]

N = 32; examined the
role of postprandial
peptide response in
compensatory eating
during 12 weeks of
aerobic exercise and in
response to high-fat, lowcarbohydrate (HFLC) and
low-fat, highcarbohydrate (LFHC)
meals; Randomized
crossover design
N = 46; Aim of this study
was to determine the
effect of 12-wk of
isocaloric programs of
moderate-intensity
continuous training
(MICT), high-intensity
interval training (HIIT), or
short-duration HIIT on
subjective feelings of
appetite, appetite-related
hormones, and reward
value of food;
Randomized crossover
design
N = 33; Investigate the
effect of 12 weeks of
aerobic (AER) compared
with resistance training
(RES) on perceived
hunger and fullness,
together with appetiterelated hormones in both
the fasted state and
postprandially;
Randomized crossover
design
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2.3.4

Diet
Diet is the pre-existing eating patterns/habits observed in an individual with

varying macronutrient intakes [32]. Regarding macronutrients within a diet, the amount
and combination of protein, carbohydrate, and fat can influence appetite-regulating
hormone concentrations, thus influencing energy intake [94]. For instance, more
significant increases of GLP-1 and PYY concentrations have been observed in males
with high-protein intakes compared to both high-carbohydrate or high-fat intakes [54,
95]. This suggests that a high-protein diet can increase sensations of satiety and
potentially lead to greater weight loss by reducing energy intake. Tischmann et al.
supported this relationship between protein and satiety by comparing diets with different
macronutrient intakes in which a high-protein/moderate-carbohydrate diet demonstrated
greater elevations in PYY than the moderate-protein/high-carbohydrate diet [94]. In
contrast, others indicate that a high-carbohydrate/fat diet had greater increases in GLP-1
than a high-protein diet [20]. These studies exhibit the influence of the diet’s
macronutrient composition on appetite-regulating hormone mediation; however, further
investigations are required to determine whether diet alterations in exercise training
interventions can further promote or maintain significant weight loss.
The studies that examine the influence of exercise-induced for weight loss
interventions on diet and the effect they have on the concentrations of appetiteregulating hormones are designated in Table 4.

30

2.3.4.1 Acute Exercise
Recent literature suggests that different exercise types can alter diet; thus,
altering appetite-regulating hormone concentration [14, 96]. Larson-Meyer observed
increases in protein and fat intake and unchanged acylated ghrelin after 60 minutes of
walking (70% VO2 peak), whereas after 60 minutes of running (70% VO2 peak),
macronutrient intake was unchanged and acylated ghrelin was increased [14]. Similarly,
Finlayson et al. demonstrated that after 50 minutes of vigorous-intensity cycling (70%
VO2 peak), subjects had a greater preference for energy-dense foods [96]. Conversely,
Jokisch and colleagues found that meal macronutrient intake did not differ after exercise
≥150 min/week or ≤60 min/week, whereas Charlot and Chapelot exhibited after 60
minutes of exercise, fat and protein intake was increased [97, 98].
2.3.4.2 Chronic Exercise
An exercise training intervention and its effect on energy and macronutrient
intakes and the appetite-regulating hormones are difficult to explain since most exercise
training studies recruit sedentary subjects at baseline [12]. Nevertheless, measured
fasting- and postprandial appetite and energy intake in subjects is typically observed in
cross-sectional studies [99, 100]. Van Walleghen and colleagues demonstrated that
exercise training subjects had greater energy and protein intake than the sedentary
subjects [100]. Regarding studies investigating the effect of exercise training
interventions on appetite-regulating hormones, the amount of literature is low [12].
However, one study found that fasting acylated ghrelin and GLP-1 concentrations were
elevated in the exercise training group compared to the sedentary group, whereas total
PYY was not significantly different between both groups [99]. This indicates that
increased exercise training duration can increase energy compensation through
manipulating appetite-regulating hormone mediation, thus reducing the
promotion/maintenance of weight loss.
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Table 4. Overview of articles that analyzed the modulating effects of diet on
concentrations of appetite-regulating hormones with exercise.
Source

Study Details

Type of Exercise
(Mode/Intensity)

Study Population

Key Findings

60 minutes of
running/60 minutes of
walking

Healthy active
women (runners =
9), aged 18-40
years, BMI 19.822.1

Exercise-induced
alterations in appetite
are likely driven by
complex changes in
appetite-regulating
hormones rather than
change in a single gut
peptide

Two conditions were
(1) moderate-intensity
exercise (Ex) which
involved stationary
cycling at
approximately 70%
maximum heart rate for
50 min, and (2) 50 min
of no exercise (NEx)

Healthy females,
aged 18-40 years,
BMI 20-25,
staff/student
population of the
University of
Leeds

Exercise-induced
changes in the hedonic
response to food could
be an important
consideration in the
efficacy of using
exercise to lose weight;
An enhanced implicit
wanting for food after
exercise may help to
explain why some
people
overcompensate
during acute eating
episodes; Individuals
could be resistant to
the beneficial effects of
exercise due to a
predisposition to
compensate for
exercise-induced
energy expenditure as
a result of implicit
changes in food
preferences

Acute Exercise
LarsonMeyer et al.
[14]

Finlayson et
al. [96]

N = 19, Plasma
concentrations of the
orexigenic peptide
ghrelin/anorexigenic
peptides PYY/GLP1/appetite ratings were
measured at 30 min interval
for 120 min, followed by a
free-choice meal
Counter-balanced cross-over
study design
Purpose of this study was to
assess the effect of a 60minute bout of exercise on
circulating concentrations
ghrelin/PYY/GLP-1;
appetite/ad libitum food
intake among women
N = 24, designed to examine
hedonic/homeostatic
mechanisms involved in the
acute effects of exercise on
food intake, conformed to a
within-subjects design
consisting of two
counterbalanced conditions
separated by approximately
one week
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Table 4. (continued)
Source

Study Details

Type of Exercise
(Mode/Intensity)

Study Population

Key Findings

After 5 min warm-up
period at 75 W, the
workload was
progressively
increased over a 10
min period until the
subjects reached 70 %
of their VO2Peak,
intensity was then
maintained over 45
min, continuous gas
exchange permitted
measurement of
EE/constant
adjustment of the
workload so that
exercise was
maintained at the
desired intensity

Non-obese males,
aged 18-25 years,
recruited through
board
advertisements in
the Paris 13
University area
(Paris, France)

Energy cost of an
aerobic exercise
session was partially
compensated over the
next 24-hr
independently of the
fatness/fitness status,
but high-fat/low-fit
individuals
compensated more
specifically on fats

Not permitted to
exercise

Healthy non-obese
young physically
active (aged 21–
35 years) and
sedentary/older
physically active
(aged 60–80
years) and
sedentary adults

T group was regular
aerobic exercise
performers doing long
distance
running/bicycling or
triathlon ([three
exercise bouts a week)
during several years
with a VO2Peak [60 ml
- min-1 kg-1 body
weight
UT group with a
sedentary lifestyle, did
not perform any
aerobic/resistance
exercise, during at
least the last 6 months
and a VO2Peak\50 ml
min-1 kg-1 body weight

Health normal
weight males
(n=20), aged 25±1
year, BMI ~22±1,
recruited through
notices posted on
the Copenhagen
University bulletin
boards/in student
magazines

Acute EI regulation is
impaired in older
adults, which is not
attenuated by physical
activity status; EI
regulation over the
course of a day is more
accurate in active vs
sedentary adults,
which may facilitate
long-term energy
balance
Satiety measures did
not differ between
groups throughout the
test; Possible that in
aerobically T subjects,
lower GIP release is
partly responsible for a
lower postprandial
incretin stimulated
insulin secretion

Acute Exercise
Charlot &
Chapelot [98]

N = 18, assessed role of
‘fatness/fitness’ in interindividual variability, withinsubject design/subjects
separated into two groups
according to their body
fatness/fitness
status/completing in random
order the two following test
conditions: (1) 60 min of
exercise (EX)/(2) 60 min of
rest (RT)

Chronic Exercise
Van
Walleghen et
al. [100]

Lund et al.
[99]

N = 54, On two occasions,
young active (n = 15), young
sedentary (n = 14), older
active (n = 14) and older
sedentary (n = 11) subjects
consumed either a highenergy yogurt preload
beverage (YP: 500 ml, 1988
kJ, men; 375 ml, 1507 kJ,
women), or no preload (NP),
30 min before an ad libitum
test meal,
N = 20, aim of this study was
to assess and compare gut
hormone response and
satiety changes after a liquid
meal intake in young, healthy
trained (T)/ untrained (UT)
males
Cross sectional in design
and a prospective
intervention study
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2.3.5

Types of Exercise Training
Several exercise-induced weight loss intervention studies support the

correlations between exercise training with appetite-regulating hormone regulation [10,
12, 13, 16, 21, 25, 27, 28]. However, these studies' methodology and outcome
measurements are widely diverse, making it difficult to determine the most efficient type
of exercise that should be applied to increase the promotion/maintenance of weight loss
[12]. The type of exercise in exercise training interventions are shaped by two factors:
mode and frequency [12, 13]. The exercise mode is typically described as either aerobic
or anaerobic, whereas exercise frequency is defined as the number of times the exercise
is performed per week [16]. Various findings indicate whether aerobic/anaerobic
exercise or a specific exercise frequency will differentially influence changes in appetiteregulating hormone concentrations [12, 16]. Recent studies that monitor these
differentiating types of exercise will be further investigated to help understand the
discrepancies in the literature [10, 12, 16].
The purpose of this section is to evaluate recent studies that observe the effect of
exercise mode and frequency on the appetite-regulating hormones designate in Table 5.
2.3.5.1 Mode
It is suggested that exercise mode has no differing effects on energy intake.
However, aerobic and anaerobic exercise have been demonstrated to have distinct and
specific appetite-regulating responses [10, 13]. Larsen et al. found differing exerciseinduced hormone responses in different exercise modes exhibited minimal effects on
perceived appetite [13]. However, further investigation is considered due to the absence
of total energy expenditure measurements and short study durations [13]. Cadieux et al.
conducted a study that evaluated these parameters and found similar findings in which
varying exercise modes exhibited no differences in energy intake [25].
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2.3.5.2 Frequency
Dorling et al. elaborate on how the number of days per week an individual
performs exercise could play a vital role in manipulating the appetite-regulating
hormones [12]. Guelfi et al. found negligible differences after a short or long duration of
exercise [33]. Recent literature on the effect of exercise frequency on the appetiteregulating hormones is scarce [12]. Two studies found that after a short and long
duration of exercise training, the hormone concentrations of PYY, GLP-1, and PYY
increased; however, there was no significant difference in the amount these hormones
increased in either durations [13, 15]. Due to the limited amount of literature, the effect of
the frequency of exercise on the appetite-regulating hormones is another parameter that
should be further investigated [12].
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Table 5. Overview of articles that analyzed the modulating effects of exercise mode and
frequency on concentrations of appetite-regulating hormones.
Source

Study Details

Methods
Compared

Study Population

Key Findings

Completed four
conditions in a
random order: 1)
non-exercise
control (CON) (50
min seated rest);
2) AE (50 min
cycling; 75%
VO2Peak); 3) SE
(10 × 8 leg
extensions; 75%
1RM); and 4) CE
(50% SE + 50%
AE)
Three, 8-hr trials:
1) Resistance
exercise: 90-min
free weightlifting
session followed
by 6.5-hr rest
period; 2) Aerobic
exercise: 60-min
run followed by 7hr rest period; 3)
Control: 8-hr rest

Sedentary overweight
males (n=12); aged 48
± 5 years; BMI: 29.9 ±
1.9

AE/SE/CE each have
own distinct

Healthy male students
(n=11); aged 21.1 ±
0.3 years; BMI: 23.1 ±
0.4; maximum oxygen
uptake: 62.1 ± 1.8
ml∙kg-1∙min-1

PYY concentrations
were greater with the
aerobic exercise trial
than the other trials;
Could indicate ghrelin
and PYY may
regulate appetite
during and after
exercise

Three randomized
crossover
sessions: 1)
Resistance
(Training protocol;
70% VO2Peak):
Performed until the
energy cost of
exercise (ExEE)
was reached; 2)
Aerobic (Treadmill;
70% VO2Peak):
Performed until the
target ExEE was
reached; 3)
Control: Had to
remain seated
during the 1-hr
session and were
only allowed to
read

Healthy sedentary
males (n=8) and
females (n=8); aged
21.9 ± 2.6 years; BMI:
22.8 ± 1.8; maximum
oxygen uptake
(VO2Peak): 53.0 ± 8.6
ml∙kg-1∙min-1

No differences in EI
between modes of
exercise, as well as
10-hr and 34-hr
following exercise;
Modality by sex
interaction was found
for acute EI (men ate
more after the
resistance session
than the aerobic
session, while women
showed no
difference); No
differences found 10hr and 34-hr postexercise in TEE,
NEAT and PEEC;
Positive correlation
found between both
modalities across
subjects for PEEC ( r
= 0.897; P < 0.01)

Mode
Larsen et al. [13]

N = 12; Completed four
conditions in random
order; Perceived
appetite/appetite-related
peptides/metabolites were
assessed before/up to 2-hr
post-condition (0P, 30P,
60P, 90P, 120P);
Randomized/counterbalanced study design

Broom et al. [10]

N = 11; Completed three
exercise trials with
different conditions;
Ratings of hunger and
plasma concentrations of
acylated ghrelin and PYY
were measured and
compared throughout the
study; Purpose was to find
the effects that resistance
exercise has on appetite;
Randomized crossover
design
N = 16; Objective was to
evaluate the effects of
exercise modality on
energy intake (EI), total
energy expenditure (TEE),
non-exercise activity
thermogenesis (NEAT),
and post-exercise energy
compensation (PEEC)
measured acutely, as well
as for 10-hr and 34-hr
following exercise;
Randomized crossover
design

Cadieux et al.
[25]
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Table 5. (continued)
Source

Study Details

Methods
Compared

Study Population

Key Findings

AER and RES
completed 12
weeks of training
(3 sessions per
week), while CON
continued their
sedentary routine

Sedentary
overweight/obese
males; aged 49 ± 7
years; BMI 30.8 ± 4.2

Aerobic exercise
training is associated
with an increase in
satiety, while an
equivalent period of
resistance training is
not

Completed four
conditions in a
random order: 1)
non-exercise
control (CON) (50
min seated rest);
2) AE (50 min
cycling; 75%
VO2Peak); 3) SE
(10 × 8 leg
extensions; 75%
1RM); and 4) CE
(50% SE + 50%
AE)
three training
groups: (1) MICT
(n = 14), (2) HIIT (n
= 16), (3) or shortduration HIIT (n =
16); three times
per week

Sedentary overweight
males (n=12); aged 48
± 5 years; BMI: 29.9 ±
1.9

AE/SE/CE each have
own distinct

Sedentary
overweight/obese
males & females
(n=30), age of 34.4 ±
8.8 years; BMI 33.3 ±
2

Suggested that
chronic HIIT has no
independent effect on
appetite or food
reward when
compared with an
isocaloric program of
MICT in obese
individuals

Frequency
Guelfi et al. [33]

Larsen et al. [13]

Martins et al. [17]

N = 33; Investigate the
effect of 12 weeks of
aerobic (AER) compared
with resistance training
(RES) on perceived
hunger and fullness,
together with appetiterelated hormones in both
the fasted state and
postprandially;
Randomized crossover
design
N = 12; Completed four
conditions in random
order; Perceived
appetite/appetite-related
peptides/metabolites were
assessed before/up to 2-hr
post-condition (0P, 30P,
60P, 90P, 120P);
Randomized/counterbalanced study design

N = 46; Aim of this study
was to determine the
effect of 12-wk of
isocaloric programs of
moderate-intensity
continuous training
(MICT), high-intensity
interval training (HIIT), or
short-duration HIIT on
subjective feelings of
appetite, appetite-related
hormones, and reward
value of food; Randomized
crossover design
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2.4

Conclusion
Understanding the effect of sex, body adiposity, diet, and exercise type

differences on appetite-regulating hormones with exercise training provides aid in the
future direction literature should take. In recent literature, it is difficult to distinguish all
the potential factors that modulate the appetite-regulating hormones in exercise training
interventions due to the heterogeneity in methodologies and outcome measurements
[12]. Although it appears that sex, body adiposity, and diet can influence concentrations
of the appetite-regulating hormones to some degree, whereas exercise mode and
frequency do not have different effects on these hormones. Further investigation into
these factors is crucial for the development of future exercise training for weight control
interventions. This information can be used by health care professionals to provide the
most accurate exercise training recommendations that give the best results among
overweight and obese populations.
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CHAPTER 3. Materials and Methods
3.1

Research Design
The study was a randomized, controlled trial that included a 12-week exercise

intervention with exercise frequencies of either six sessions (days) per week, two
sessions per week, or a sedentary control group (no exercise), blocked by sex.
Concentrations of ghrelin, leptin, glucagon-like peptide 1 (GLP-1), and insulin were
assessed before (fasting, minute 0) and after a standardized meal at minute 15, 30, 45,
60, 90, 120, 150, and 180 at baseline and after the 12-week exercise intervention (post).
Regarding exercise treatments, subjects were directed to only aerobic exercise (walking,
running, biking, treadmill, elliptical, or stationary bike). A Polar A-300 heart rate monitor
(watch and chest-/waist-strap) had to be worn during exercise, with subjects reporting
back to the lab weekly to download and record each exercise session. Weekly meetings
allowed to monitor adherence to the prescribed amount of exercise (2- or 6-days per
week) and evaluate exercise-induced energy expenditure.
3.1.1

Recruitment
Recruitment occurred in and around Lexington, Kentucky, beginning in the winter

of 2018 and ending in the spring of 2019. The inclusion criteria included BMI between 25
to 35 kg/m2, 18 to 40 years of age, no physical limitations or major health problems, and
not pregnant or planning a pregnancy in the next six months. The exclusion criteria
included dieting over the past three months, tobacco use, taking metabolic altering
medications, regularly exercising in the last six months, and any medical condition
preventing safe exercise. The subjects collected had a BMI ranging from 25 to 35 kg/m2,
were weight-stable (not lost or gained 5% of their current body weight in the last six
months), sedentary (not engaging in exercise), free of any metabolic or cardiovascular
disease, not pregnant or nursing, and not participating in a weight loss diet or taking any
appetite-regulating medications.
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3.1.2

Subjects
A total of 53 participants volunteered and were randomized into one of three

groups. Of these, 44 participants completed the study (32 women), with six (four women)
withdrawing for personal reasons, and two female participants were excluded for
noncompliance. Six individuals (3 females) did not have valid data for the hormonal
mediators of hunger (processing or equipment error). Thus, 37 subjects (29 females)
completed the 12-week intervention and were included in the analyses. All subjects had
a body mass index (BMI) ranging from 25-35 kg/m2, were weight-stable (not lost or
gained 5% of their current body weight in the last six months), sedentary (not engaging
in exercise), free of any metabolic or cardiovascular disease, not pregnant or nursing,
and not participating in a weight loss diet or taking any appetite-regulating medications.
The study was approved by the University of Kentucky Institutional Review Board and is
registered with Clinicaltrials.gov identifier: NCT03413826.
3.1.3

Procedures
Subjects provided their written informed consent and were screened of eligibility

criteria at an initial screening and consent visit. Screening of eligibility criteria included
completing a health history and physical activity readiness questionnaire (PARQ), the
Preference for and Tolerance of the Intensity of Exercise Questionnaire (PRETIE-Q),
and an online survey of their weight loss history. Physical activity was objectively
assessed for seven days before completing the baseline testing by an ActiGraph
accelerometer that was provided and worn by each participant. During subsequent visits
before and after the exercise intervention, the energy expenditure rate, resting energy
expenditure (REE), body composition, and hormonal response to a standardized
breakfast meal were obtained.
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3.1.4

Exercise Intervention
A Polar A-300 heart rate monitor (watch and chest-/waist-strap) was provided to

each subject to be worn during each exercise session of the 12-week intervention. The
intervention was based on a previous study that demonstrated a compensatory
response of roughly 1,000 kcal/day regardless of kcal expended per week (either 3,000
or 1,500 kcal) [101]. In the present investigation, subjects were instructed to exercise
either 2- or 6-days per week (exercise group) or remain sedentary (control group).
Subjects in the 2-day per week group were instructed to complete at least two exercise
sessions per week (90 to 120 minutes per session), whereas the 6-day per week group
was to complete at least six exercise sessions per week (40 to 60 minutes per session).
Those in the exercise group were instructed to report back to the lab weekly to meet with
the research staff where exercise sessions recorded on the Polar A-300 were
downloaded using the PolarFlowTM software. During each download meeting session,
research staff provided feedback to subjects on their amount of time and energy
expended from each session's prior week. These meetings also allowed the research
staff to evaluate the exercise sessions and track compliance with the intervention.
Compliance was defined as completing at least 90% of the instructed exercise sessions
per month. Subjects that did not complete at least 90% of expected exercise sessions
per month were dropped from the study. The exercise session reports that were
downloaded provided the amount of time the subject spent in each heart rate zone,
which was used to calculate the energy expended during exercise (exercise energy
expenditure, ExEE). The intensity was self-selected as long as subjects were in at least
in HRR zone 1. Dietary habits were instructed not to be changed during the 12-week
intervention.
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3.2
3.2.1

Assessments
Physical Activity
At baseline, habitual, free-living physical activity was measured by an ActiGraph

accelerometer (GT3X+ model; Pensacola, Florida) to ensure subjects were sedentary,
i.e., not engaging in structured exercise, before baseline testing. Subjects wore the
monitor at the waistline during all awake hours, apart from bathing and swimming. The
monitor's data was recorded weekly to determine minutes of vigorous physical activity
(VPA) with consecutive strings of zeros greater than 20 minutes or non-wear time,
removed from recordings. Data of VPA was determined by using the Crouter et al.
algorithm, and Freedson cut points. VPA was used to determine exercise behaviors
instead of the more typical moderate to vigorous physical activity (MVPA), as nonexercise behaviors such as walking would be included in MVPA but not necessarily
indicative of purposeful exercise. This was the case with many subjects who were part of
a large University system and required to walk across a sprawling campus daily.
3.2.2

Rate of Energy Expenditure
The rate of energy expenditure at five different heart rate zones was calculated

using a graded exercise treadmill test using the Trackmaster TMX428 Metabolic cart
interface treadmill with integrated 12-lead ECG. Indirect calorimetry was used to analyze
oxygen (O2) consumption, and carbon dioxide (CO2) expired. The initial start of the test
included a five-minute warm-up walk at 0% grade and 3.0 mph. After completion, the
treadmill grade was increased to 2.5% for three minutes and every three minutes after
that until an approximate 10-beat peat per minute increase in heart rate was produced
from the previous stage with speed unchanged at 3.0 mph. Subjects continued the test
until a heart rate of 85% heart rate reserve (HRR) was achieved or if they could not
continue. The rate of energy expenditure (kcal per minute) was determined by the Weir
equation [102] for each heart rate zone. Precisely, the rate of energy expenditure (kcal
42

per minute) at different heart rate zones was calculated by regressing the average rate
of energy expenditure during the last 30-seconds of each stage against the average
heart rate from the last 30-seconds of the corresponding stage. Subjects completed the
following test at baseline and at six-weeks to formulate a new regression equation and
thus new values for the rate of energy expenditure for each stage to account for
improvements in fitness when starting an exercise intervention. Using the average rate
of energy expenditure at each heart rate zone and the time spent exercising in each
zone (provided from Polar Heart Rate Monitor), the training-induced exercise energy
expenditure (TrEE) of each session was calculated, which was used to determine total
exercise energy expenditure (ExEE) and compensation index (CI).
3.2.3

Resting Energy Expenditure
REE was measured at baseline and post as this value was needed to calculate

ExEE and alterations in metabolic activity. Indirect calorimetry (Quark RMR; Cosmed
USA, Chicago, IL) with a ventilated canopy was used to measure REE. Participants
were instructed to arrive fasted (~10-hr) and remain awake for the 45-minute test. REE
was measured for 30-minutes after a 15-minute rest in the supine position. The
additional 15-minutes were required to develop the steady-state, defined as <10%
fluctuation in O2 consumption and <5% fluctuation in the respiratory quotient (RQ), which
is needed for a valid REE.O2 consumed, and CO2 produced determined 24-hour REE
(kcal) using the Weir equation [102].
3.2.4

Body Composition
A GE Lunar iDXA machine measured body composition for each participant at

baseline and post. The GE Lunar iDXA machine, performed using thick mode
recommended by the software, provided a total body scan to obtain the absolute and
relative measurements of total body and regional soft tissue masses such as fat mass
(FM), fat-free mass (FFM), and mineral-free lean (MFL). iDXA scans were analyzed
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using GE Lunar enCORE Software (13.60.033) with calibration performed before each
session. From this assessment, FM and FFM measurements were obtained and used to
calculate accumulated energy balance (AEB) since alterations in energy balance have
been observed to correspond with changes in body composition [103].
3.2.5

Appetite-Regulating Hormones
The appetite-regulating hormone’s concentrations were obtained by standard

blood collection procedures at the outpatient wing of the University of Kentucky’s CCTS
hospital after a 10 to 14-hr overnight fast. Concentrations of ghrelin, leptin, GLP-1, and
insulin were assessed before (fasting, minute 0) and after consumption of a
standardized breakfast meal, that was 20% of the subjects’ estimated energy needs.
Selection of these specific hormones based on the most common hormones implicated
in exercise-induced increases in appetite [13]. The estimated energy needs were found
based on the subject’s REE and the sedentary activity factor of 1.4. The standardized
breakfast meal consisted of one Nutra-grainTM bar and cornflakes with 2% milk (an
unsweetened soymilk substitute was optional for lactose-intolerant participants). The
completion of the meal consumption was instructed to be within 15 minutes; after
consumption, the first blood draw initiation was initiated. The blood draws were
completed in 15-minute increments 15, 30, 45, 60 for the first hour and 30-minute
increments (90, 120, 150, 180) during the second hour. EDTA-coated and serum tubes
were used to collect the blood samples. Serum insulin was measured with a
chemiluminescent immunometric assay (Siemens), whereas ghrelin, leptin, and GLP-1
were measured using enzyme-linked immunosorbent assay (ELISA, Millipore, Phoenix
Pharmaceuticals, Alpco).
3.2.6

Energy Compensation
To calculate compensation for energy expended during exercise, AEB was

calculated from FM and FFM changes and converted to kcal equivalents. Gaining 1kg
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FM and 1kg FFM reflected as 12,000 kcal and 1,780 kcal, respectively, whereas losing
1kg FM and 1kg FFM reflected as -9,417 kcal and -884 kcal, respectively [104, 105].
After calculating AEB, ExEE was calculated from training-induced energy expenditure
(TrEE) with an addition of 15% excess post-exercise energy expenditure acquired after
exercise sessions (TrEE * 0.15), and subtracting the basal energy expenditure (REE *
1.2) that would have occurred during the exercise session so not to include it twice [106].
The final equation to calculate ExEE is as follows: ExEE = (TrEE * 0.15) + (TrEE –
training duration * (REE * 1.2)). CI was calculated to assess the percentage of ExEE
compensated for. The total amount of kcal compensated was calculated first by adding
AEB (a negative value if participants decreased body weight) to ExEE. In the following
equation, (ExEE + AEB)/ExEE x 100%, the number of total kcal compensated was
converted to form a percentage, referred to as percent kcal compensated, or CI. Thus, a
positive CI depicts a negative energy balance less than ExEE (participants at least
partially compensated for the energy they expended during exercise). A negative value
indicates that energy balance is more negative than expected, or the participants lost
more weight than energy expended. When CI equals zero, subjects lost the same weight
as the energy they expended, i.e., they did not compensate.
3.3

Statistical Analysis
T-tests were performed to determine baseline group differences in sex, age, BMI,

VPA, REE/kg FFM, RQ, VO2 peak, and exercise training-induced variables (ExEE, AEB,
and CI) at post-testing. The primary outcomes were CI, kcal compensated, percent body
fat loss, and appetite-regulating hormone concentrations with interest in how these
variables related to exercise dose defined as sessions per week, ExEE per week, time
spent exercising per week, and exercise intensity (percent time spent exercising in HRR
zones 3-5). Linear mixed-effects models were used to model the relationships between
time point (12 weeks vs. baseline) and group over time (minutes 0 to 180) for the
45

concentrations of appetite-regulating hormones (leptin, ghrelin, GLP-1, and insulin).
Post-prandial changes in appetite-regulating hormone concentrations were evaluated as
changes in the area under the curve (delta-AUC), calculated by the trapezoidal rule.
Over time group differences, between-group differences, and group-time interactions in
primary outcomes were tested by repeated-measures two-way ANOVA, with sex and
age included as covariates.
Additionally, ANCOVA analyses were performed for the delta-AUC of appetiteregulating hormones and body weight/FM; both bodyweight and FM were presented as
percent change and raw values. Bivariate correlation analysis was used to calculate
correlates of CI and percent body fat loss. Linear regression analyses were used to
predict CI and percent body fat loss using leptin delta-AUC, ghrelin delta-AUC, exercise
group (exercise frequency), time spent exercising per week, ExEE per week, and
exercise intensity as independent variables. All analyses were performed in IBM SPSS
Version 26 (IBM Corporation, Armonk, NY).
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CHAPTER 4. Results
In Table 6, no differences in baseline characteristics (sex, age, BMI, VPA, REE/kg
FFM, RQ, VO2 peak) between groups. Exercise training-induced variables and
differences in weekly ExEE, time spent exercising, and percent body fat loss are found
in Table 7. All participants engaged in less than 90 minutes of VPA per week with an
average of 47.73 ± 6.13 in the 6-day per week group and an average of 52.31 ± 4.62 in
the 2-day per week group. As expected, the 6-day group expended more energy and
exercised longer per week than the 2-day (P<0.05). CI did not differ between groups
(P>0.05); as such, only the 6-day group lost FM, P=0.03. The control group % body fat
loss change was different from both exercise groups, P<0.05. Results from the mixedeffects models indicated only ghrelin (P=0.03) and leptin (P<0.01) had significant group
by time interactions, decreasing to a greater extent in 6d than 2d or control.
Changes over time and between groups for delta-AUC of the appetite-regulating
hormones are presented in Table 8. Between-group changes for Leptin-delta-AUC in
both the 6-day and 2-day groups were different from the control group. Changes over
time (baseline to post) in leptin-delta-AUC were only different in the 6-day per week
group (P<0.05). No other hormones (delta-AUC) demonstrated significant changes over
time or between groups.
Listed in Tables 9 and 10 are the results from the linear regression analyses
predicting CI and percent body fat change. Leptin-delta-AUC was the only independent
predictor of CI while controlling for percent body fat loss change and ExEE. Ghrelindelta-AUC was the only independent predictor of percent body fat loss change when
controlling for CI and ExEE.
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Table 6. Baseline differences in demographics (sex, age, BMI) vigorous physical
activity, and metabolic rates (REE/Kg FFM) of participants between groups (includes
all randomized participants).
6-day per week group
N=19

2-day per week group
N=20

Control
N=14

68.40

85.00

78.80

Age (years)

29.32 ± 7.27

28.56 ± 5.85

26.00 ± 7.80

BMI1

29.00 ± 2.87

30.51 ± 3.47

29.36 ± 2.87

VPA2

9.08 ± 12.88

8.57 ± 17.45

12.91 ± 19.87

REE/Kg FFM3

31.52 ± 4.76

33.86 ± 4.75

33.37 ± 4.62

RQ4

0.93 ± 0.10

0.90 ± 0.09

0.92 ± 0.06

VO2 Peak5

39.76 ± 4.56

38.45 ± 2.57

39.95 ± 4.84

Sex (% female)

Data as mean ± SD.
1BMI:

Body Mass Index, kg/m2.

2VPA:

Minutes of VPA assessed objectively assessed via accelerometry using Freedson cut points.

3REE/Kg

FFM: Resting energy expenditure per kg FFM, in kcal per 24-hr, assessed from indirect
calorimetry. Calculated via the Weir equation from O2 consumed and CO2 produced.

4RQ:

Respiratory quotient, CO2 produced divided by O2 consumed during resting energy expenditure test.

5VO
2

Peak: Estimated from submaximal exercise test, mL∙kg-1∙min-1.
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Table 7. Resulting data from the exercise intervention between groups that exercised.
6-day per week group
N=15

2-day per week
group
N=17

All participants
N=32

320.50 ± 20.40

188.80 ± 12.00

249.41 ± 16.85

% Time in Zone 3-52

47.73 ± 6.13

52.31 ± 4.62

50.32 ± 3.69

% Time in Zone 1-23

52.11 ± 5.68

47.69 ± 4.62

49.67 ± 3.69

ExEE/week4, *

2,753.50 ± 144.90

1,490.70 ± 122.10

2,041.68 ± 150.80

Kcal compensated/week5

1,309.86 ± 274.50

715.42 ± 268.60

961.39 ± 198.70

Total exercise time6

3,944.20 ± 242.80

2,265.40 ± 143.40

2,992.90 ± 202.20

Total ExEE7

33,091.00 ± 2,112.80

17,562.00 ± 1,547.70

24,291.00 ± 1,895.00

Total kcal compensated8

15,718.00 ± 3,294.1

8,585.00 ± 3,223.00

11,537.00 ± 2,384.20

−16,789.00 ± 3,589.80

−8,977.30 ± 3,515.30

−12,363.00 ± 2,586.70

CI10

55.43 ± 10.16

49.31 ± 20.56

50.25 ± 12.27

Kg weight loss11

−1.04 ± 0.45^

−0.76 ± 0.60

−0.59 ± 0.38

% weight loss12

−1.48 ± 0.64^

−0.84 ± 0.66

−1.09 ± 0.45

Kg body fat loss13, *

−1.82 ± 0.39^

−0.64 ± 0.44

−0.58 ± 0.34

% Body fat loss14, *

−7.70 ± 2.04^*

−1.86 ± 1.27#

−4.43 ± 1.30

1.06 ± 0.94

−1.45 ± 1.08

−0.38 ± 0.81

Exercise Time/week1, *

AEB9

Delta REE/kg FFM15
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Table 7. (continued)

Delta RQ16

6-day per week group
N=15

2-day per week
group
N=17

All participants
N=32

−0.11 ± 0.06

−0.09 ± 0.07

−0.09 ± 0.04

Data are mean ± SE, only individuals who completed intervention included.
*: Indicates significant differences between groups, P ≤ 0.05.
^: Indicates significant change over time (change different from zero), P ≤ 0.05.
*, #: Like symbols indicated significant differences between groups, P ≤ 0.05.
1Exercise

time/week: Amount of time (min) spent exercising per week.

2%

Time in zone 3-5: Percentage of time exercising spent in HR zones 3, 4, or 5 (70%–100% HRR).

3%

Time in zone 1-2: Percentage of time exercising spent in HR zones 1 or 2 (50%–69% HRR).

4ExEE/week:

Exercise energy expenditure (in kcal) per week.

5Kcal

compensated/week: Energy (kcal) compensated for each week calculated by adding AEB + total
ExEE together and dividing by 12.
6Total

exercise time: Total amount of time spent exercising during the entire 12-wk intervention (in min).

7Total

ExEE: Total exercise energy expenditure of the 12-wk intervention (in kcal).

8Total

kcal compensated: Total amount of kcal compensated, calculated by adding AEB + total ExEE
together.
9AEB:

Accumulated energy balance, calculated from changes in bodily energy stores (changes in fat and
lean mass) converted to kilocalorie equivalents.
10CI:

Percentage of kcal compensated for, calculated as (ExEE + AEB) / ExEE.

11Kg

weight loss: Kg of total body weight lost after the 12-wk intervention.

12%

weight loss: Kg of weight loss divided by baseline body weight (in kg).

13Kg
14%

body fat loss: Kg of body fat lost after the 12-wk intervention.

body fat loss: Kg of body fat loss divided by baseline body fat (in kg).

15Delta

REE/kg FFM: Changes in REE per kg of FFM from baseline to post (post value subtracted by
baseline value).
16Delta

RQ: Changes in respiratory quotient during rest from baseline to post (post value subtracted by
baseline value).
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Table 8. Comparing pre- and post-prandial differences between groups and over time
of the changes in AUC for concentrations of Leptin, Acylated Ghrelin, GLP-1, and
Insulin.
6-day per week group
N=12

2-day per week group
N=14

Control
N=11

Ghrelin ΔAUC

−5321.99 ± 4304.09

1778.38 ± 2114.07

−4028.67 ± 2440.11

Leptin ΔAUC

−998.57 ± 414.16 * #

−604.53 ± 617.98 ^

1118.31 ± 650.77 * ^

Insulin ∆AUC

−1090.49 ± 759.40

410.80 ± 625.16

315.39 ± 1184.69

GLP-11 ∆AUC

−27.10 ± 20.85

−19.12 ± 22.86

−25.90 ± 12.85

Data as mean ± SE.
*, ^: Like symbols indicated significant different between groups, P ≤ 0.05.
#: Indicates significantly different from zero (change from baseline is significant), P ≤ 0.05.
1GLP-1:

Glucagon-Like Peptide 1
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Table 9. Regression models predicting CI among exercise groups. The control group
did not have a value for ExEE and thus did not have values for CI.
Effect

β

SE

P

Partial Correlation1

Intercept

47.87

27.85

0.10

Leptin2 ΔAUC

0.01

<0.01

<0.01

0.60 *

Exercise frequency3

23.98

23.01

0.17

0.31

Exercise time/week4

−0.13

0.11

0.24

−0.27

ExEE/week5

0.13

0.02

0.47

0.17

% Time in zones 3–56

0.09

0.35

0.81

0.06

% body fat lost7

5.79

1.25

<0.01

0.73 *

Intercept

86.42

7.05

<0.01

Leptin2 ΔAUC

0.01

<0.01

<0.01

0.64 *

% body fat lost7

4.28

0.88

<0.01

0.71 *

Full model of all predictors

Reduced model of significant predictors

1Partial

correlation also displayed.

*: Indicates significant correlation
2Leptin

ΔAUC: Changes in area under the curve for changes in concentrations of leptin pre-meal (fasting)
to 2-hrs post-prandial.
3Exercise

frequency: Participants were randomly assigned to exercise 6-days per week or 2-days per

4Exercise

time/week: Amount of time (min) spent exercising per week.

week.

5ExEE/week:

Exercise energy expenditure (in kcal) per week.

6%

Time in Zone 3-5: Percentage of time exercising spent in HR zones 3, 4, or 5 (70%–100% HRR).

7%

body fat loss: Kg of body fat loss divided by baseline body fat in kg.
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Table 10. Regression models predicting percent body fat loss among exercise groups.
The control group did not have values for many independent variables and predictors.
Effect

β

SE

P

Partial Correlation1

Intercept

5.62

4.78

0.26

Leptin2 ΔAUC

<0.01

<0.01

0.07

0.43

Ghrelin3 ΔAUC

<0.01

<0.01

0.03

0.50 *

Exercise
frequency4

0.23

4.00

0.95

0.01

Exercise
time/week5

0.02

0.02

0.22

0.29

ExEE/week6

−0.01

0.03

0.05

−0.45 *

% Time in zones
3–57

0.07

0.06

0.31

−0.25

Full model of all predictors

Reduced model of significant predictors
Intercept

5.80

3.19

0.08

Ghrelin3 ΔAUC

<0.01

<0.01

<0.03

0.44 *

ExEE/week6

−0.01

<0.01

0.01

−0.54 *

1Partial

correlation also displayed.

*: Indicates significant correlation.
2Leptin

ΔAUC: Changes in area under the curve for changes in concentrations of leptin pre-meal (fasting)
to 2-hrs post-prandial.
3Ghrelin

ΔAUC: Changes in area under the curve for changes in concentrations of leptin pre-meal
(fasting) to 2-hrs post-prandial.
4Exercise

frequency: Participants were randomly assigned to exercise 6-days per week or 2-days per

5Exercise

time/week: Amount of time (min) spent exercising per week.

week.

6ExEE/week:

Exercise energy expenditure (in kcal) per week.
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CHAPTER 5. Discussion
The present study evaluated aerobic exercise's effect at varying exercise
frequencies on post-prandial hunger hormone responses after a 12-week exercise
intervention. We evaluated the effect these hormonal changes have on the
compensatory response to exercise and percent body fat loss change using a linear
regression model to determine independent predictors of these hormonal changes.
Determining these predictors can help reduce or slow the obesity epidemic by altering
the way exercise intervention treatments are instituted. Recent research has indicated
that exercise can alter appetite-regulating hormones; however, it is not known which
variables predict these hormonal changes [2, 5, 8, 9]. Automatic compensatory
responses to exercise can decrease the success of an exercise for weight loss
intervention by resisting negative energy balance. These responses include decreases
in resting and activity-induced energy expenditure [107, 108]. However, the primary
compensatory response to an exercise-induced energy deficit is increased energy
intake, controlled by the individual [1, 6, 19]. It is uncertain how appetite-regulating
hormones affect energy compensation with exercise or other factors of the exercise
program that influences these purported changes. From this evidence, we demonstrate
the link between changes in appetite-regulating hormone concentrations, compensatory
responses, and body fat change with exercise.
One of the hypotheses proposed in the present study was that increases in ghrelin
concentrations and decreases of leptin, insulin, and GLP-1 concentrations in response to
a meal would be greater when exercising 6-days per week than 2-days per week for 12
weeks did not hold. Only leptin was significantly different between groups, with the 6-day
per week group decreasing to a greater extent than the 2-day per week group. This
leptin change was most likely due to the 6-day per week group losing more body fat than
the 2-day per week group. Many studies have demonstrated that leptin levels are
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proportional to the degree of adiposity, with concentrations elevated among overweight
and obese populations [8, 9]. However, since leptin is a satiety-inducing hormone, one
may assume that greater increases in this hormone would reduce food consumption and
improve the compensatory response to exercise. The present study demonstrated that
greater leptin-delta AUC reductions predicted less energy compensation even when
controlling for ExEE and body fat loss. Therefore, regardless of how much one exercises
or how much fat one loses, the amount of leptin can predict the amount of kcal one
compensates for in healthy and overweight to obese individuals. This may be due to
exercise increasing leptin sensitivity, making it more effective as a satiety-inducing
hormone.
The other hypothesis proposed in the present study that changes in appetiteregulating hormones after 12 weeks of exercise will predict body fat loss, with changes
in ghrelin being negatively associated with body fat loss and leptin, GLP-1, and insulin
being positively associated with body fat loss, only held with ghrelin. The present study
observed changes in ghrelin-delta-AUC predicted percent body fat loss change even
when controlling for CI and ExEE. Thus, greater increases in post-prandial ghrelin
changes caused greater body fat loss, regardless of the length of exercise (ExEE) or the
amount of kcal you compensate for (CI).
This study is not without limitations. The exercise sessions that participants
performed were unsupervised. Therefore, it was possible that additional exercise not
being recorded, or not strictly aerobic exercise, was undertaken; nevertheless, no
evidence led to this suspicion. Sex differences were not observed in the study likely due
to the greater sample number of females. Regarding female participants, another
limitation was not assessing the stage of the menstrual cycle. The menstrual cycle stage
has been indicated in recent literature to alter energy intake and energy expenditure;
thus, affecting compensatory response calculations made for certain subjects [64].
55

CHAPTER 6. Conclusion
Several studies have demonstrated changes in appetite-regulating hormones after
acute- and long-term or moderate and intense exercise. However, the amount of
research on changes in the hormones and their influence on compensatory response to
exercise is limited [10-17, 21, 25-28]. This can pose limitations to health care
professionals when prescribing the most effective exercise regimen in promoting
sufficient weight loss among overweight and obese individuals. Based on the present
study, understanding the influence of the appetite-regulating hormones on compensatory
responses to exercise is essential for a successful weight loss intervention.
From the results, leptin changes predict the amount of kcal one compensates for,
regardless of the length of exercise or fat one loses. Being overweight and obese with a
larger amount of FM than FFM diminishes the success of sufficient weight loss due to
hormone imbalances that directly influence compensatory responses that can resist the
maintenance of negative energy balance making weight loss a greater challenge [8, 9,
21]. These leptin reductions caused less energy compensation, whereas reductions of
ghrelin caused greater body fat loss; thus, analyzing leptin and ghrelin concentrations
may be beneficial for weight loss success paired with exercise. One would think that
reductions in leptin would cause greater energy compensation; however, we observed
that reductions in leptin’s concentration caused less energy compensation. This leptin
observation can be described by decreased leptin resistance due to reduced leptin
concentration; thus, increasing leptin's receptors' sensitivity. Several research
investigations have proposed many mechanisms that explain this phenomenon of leptin
resistance [109]. The common conclusion of the mechanism that plays a vital role in
leptin resistance is alterations in cellular Ob-Rb receptor signaling [109]. Leptin
resistance is analogous to insulin resistance, in which physiological feedback
mechanisms limit Ob-Rb receptor signaling in obese states; thus, reducing the appetite56

regulating effects of leptin [109]. It is concluded that post-prandial changes in ghrelin and
leptin are a crucial modulator in one’s success in an exercise for weight loss
intervention, regardless of the length of exercises. Still, the physiological mechanisms
that control compensatory responses are complex and could make it challenging to
provide appropriate and effective treatment. The study's findings indicate the importance
of the implications of these changes that can be a predictor for successful weight loss;
however, future research is needed to evaluate the success of hormonal manipulation
for sufficient weight loss among overweight and obese subjects.
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